Cargando…
Overexpression of PAK1 Promotes Cell Survival in Inflammatory Bowel Diseases and Colitis-associated Cancer
BACKGROUND: Chronic gut inflammation predisposes to the development of colorectal cancer and increased mortality. Use of mesalamine (5-ASA) in the treatment of ulcerative colitis modulates the risk of neoplastic progression. p21 activated kinase 1 (PAK1) mediates 5-ASA activity by orchestrating MAPK...
Autores principales: | Khare, Vineeta, Dammann, Kyle, Asboth, Mario, Krnjic, Anita, Jambrich, Manuela, Gasche, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345971/ https://www.ncbi.nlm.nih.gov/pubmed/25569743 http://dx.doi.org/10.1097/MIB.0000000000000281 |
Ejemplares similares
-
Republished: Tracing PAKs from GI inflammation to cancer
por: Dammann, Kyle, et al.
Publicado: (2014) -
A Novel PAK1–Notch1 Axis Regulates Crypt Homeostasis in Intestinal Inflammation
por: Frick, Adrian, et al.
Publicado: (2020) -
Mesalamine and azathioprine modulate junctional complexes and restore epithelial barrier function in intestinal inflammation
por: Khare, Vineeta, et al.
Publicado: (2019) -
Thymoquinone attenuates tumor growth in Apc(Min) mice by interference with Wnt-signaling
por: Lang, Michaela, et al.
Publicado: (2013) -
PAK1 modulates a PPARγ/NF-κB cascade in intestinal inflammation
por: Dammann, Kyle, et al.
Publicado: (2015)